tirzepatide. Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity certified physicians Tirzepatide for Medical Weight Loss

Retrieved 30 October 2025

This allows the same vial to be used multiple times while maintaining a sterile environment when proper laboratory handling procedures are followed

[168] [169] In June 2025, the European Medicines Agency recommended that the product information for semaglutide medicines be updated to include non-arteritic anterior ischemic optic neuropathy (NAION) as a very rare side effect, [170] while the World Health Organization concluded that the risk management plan for semaglutide should be revised to include NAION as a potential risk

Higher expression of PTGS2, COX-2, and mPGES in both ferroptosis and BD makes a compelling argument for ferroptosis being a key component of BD pathogenesis